Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.12
Bid: 0.11
Ask: 0.13
Change: 0.00 (0.00%)
Spread: 0.02 (18.182%)
Open: 0.12
High: 0.12
Low: 0.12
Prev. Close: 0.12
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Aug 2023 17:32

RNS Number : 1253I
Deltex Medical Group PLC
02 August 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0059337583

Issuer Name

DELTEX MEDICAL GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Herald Investment Management Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Discretionary investment management clients of Herald Investment Management Limited

5. Date on which the threshold was crossed or reached

02-Aug-2023

6. Date on which Issuer notified

02-Aug-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.830000

0.000000

5.830000

107719035

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0059337583

107719035

5.830000

Sub Total 8.A

107719035

5.830000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

02-Aug-2023

13. Place Of Completion

London,UK

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAKPAEAPDEFA
Date   Source Headline
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France
11th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSNotice of Interim Results
31st Aug 20177:00 amRNSInvestor Event
2nd Aug 201712:59 pmRNSHolding(s) in Company
28th Jul 201711:10 amRNSHolding(s) in Company
27th Jul 20175:24 pmRNSHolding(s) in Company
21st Jul 20177:01 amRNSShare placing
21st Jul 20177:00 amRNSPre-close Trading Update
13th Jun 20179:30 amRNSDirector/PDMR Shareholding
9th Jun 20171:25 pmRNSResult of AGM
9th Jun 20177:00 amRNSExcellent Results from New Trial
9th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSPatent Grant
26th May 20177:00 amRNSLaunch of ODMV+ system for veterinary anaesthesia
4th May 20177:00 amRNSNew Functionality on CardioQ-ODM+ Monitor Platform
3rd May 20172:20 pmRNSExercise of Options
3rd May 20172:15 pmRNSPublication of Annual Report & Notification of AGM
27th Apr 20177:01 amRNSDeltex awarded EU Horizon 2020 Phase 1 grant
27th Apr 20177:00 amRNSResults for the year ended 31 December 2016
20th Apr 201712:25 pmRNSInvestor open day and notice of results
4th Apr 201711:51 amRNSExercise of Options
28th Mar 20176:05 pmRNSHolding(s) in Company
22nd Mar 20177:15 amRNSGrant of Options
22nd Mar 20177:00 amRNSShare Issues
23rd Feb 20177:00 amRNSNew Monitor Sales in USA and UK
25th Jan 20177:00 amRNSSouth Korean broadens ODM reimbursement
18th Jan 20177:00 amRNSTwo additional US platform programme accounts
18th Jan 20177:00 amRNSTrading Update
30th Nov 20167:00 amRNSAdditional US platform programme account
4th Nov 20167:00 amRNSNHS hospital invests in ODM equipment
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20167:00 amRNSTwo new US platform programme accounts opened
10th Mar 20167:00 amRNSPlacing and Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.